"Designing Growth Strategies is in our DNA"

Antithrombin Market Size, Share and Industry Analysis By Application (Therapeutics, Research, Diagnostics & Others), Source (Human, Goat Milk), Dosage Form (Lyophilized, Liquid) & Regional Forecast, 2019 - 2026

Region : Global | Published Date: Jun, 2019 | Report ID: FBI100470

 

KEY MARKET INSIGHTS

Play Audio Listen to this report overview

Antithrombin (AT) is a type of protein in human blood which plays important role prevention of blood clotting as it acts as a natural blood thinner and extensively used while performing surgical procedures in the patient with low antithrombin levels.


The deficiency of antithrombin may lead to the risk of thromboembolism, which can result in excessive bleeding during surgical procedures. Antithrombin III is preferentially utilized for extracorporeal membrane oxygenation during cardiopulmonary bypass. There are certain methods by which antithrombin deficiency can be measured. Some of the tests such as AT (antithrombin) Activity and test of antithrombin antigen level are highly practiced by physicians. Inherited antithrombin deficiency and acquired deficiency caused by other diseases are two main prominent risk factors for causing antithrombin deficiency.


Get comprehensive study about this report by, request a free sample copy


"Therapeutics is the Most Attractive Application Type"


Therapeutics application segment accounted for a market share of 95.7% in 2018. The global market is expected to witness growth due to the increasing prevalence of antithrombin deficiency and growing incidence of bleeding during surgical procedures. According to the data published by the U.S. Department of Health & Human Services in 2018, antithrombin deficiency is expected to occur in about 1 in 2,000 people across the globe. Combined with this, growing surgical procedures and progress in factors responsible for rising prevalence of antithrombin deficiency such as nephrotic syndrome, liver failure, severe burns and others are secondarily projected to affect the antithrombin market growth during the forecast period.


Based on source, the goat milk antithrombin segment is likely to be the fastest growing segment during the forecast period, owing to the proven clinical efficacy. In terms of dosage form, the lyophilized antithrombin segment is likely to dominate the market during the forecast period.


To get details on market share, speak to analyst


Regional Analysis


"The Asia Pacific to Emerge as the Most Lucrative Market for Antithrombin" 


Asia Pacific Antithrombin Market, 2018

To get geographical overview of this market, request a free sample copy


Asia Pacific accounted for USD 179.7 Million in 2018, and is anticipated to emerge as the fastest growing region in market during the forecast period. This is attributed to the growing prevalence of congenital antithrombin III deficiency. Along with this, increasing demand for reduction in rate of surgical mortality as well as increasing life expectancy are anticipated to plays an important role in increased adoption of antithrombin during the forecast period. Additionally, Europe holds huge potential for antithrombin market growth, owing to considerable adoption of human antithrombin based products in countries such as Germany, U.K., France, and others.


Key Market Drivers 


"Shire, CSL Behring, and Grifols to Account for Prominent the Share in Terms of Revenue"


Shire, CSL Behring, and Grifols emerged as the leading players cumulatively with the highest market share in 2018, as these companies engaged in offering the most commonly used human antithrombin based anticoagulants. Combined with this, these companies have a strong focus on reinforcing strategies for the development of robust distribution network and strong penetration in the market in Europe. Some of the major companies that are present in the global antithrombin market are LFB USA, Kedrion S.p.A., Octapharma AG, Lee Biosolutions, and Scripps Laboratories Inc


Key companies covered in the report



  • LFB USA

  • Grifols

  • Shire Plc.

  • CSL Limited

  • Kedrion S.p.A.

  • Octapharma AG

  • Lee Biosolutions

  • Scripps Laboratories Inc.

  • Other prominent players


Report Overview


Growing adoption of antithrombin combined with heparin is expected to positively impact the growth of the market. Existing new product development and ongoing clinical trials to discover novel applications of antithrombin, cumulatively considered to support the growth of market during the forecast period.


The report provides qualitative and quantitative insights of antithrombin industry and detailed analysis of market size & growth rate for all possible segments in the market. The market is segmented on the basis of, source type, and dosage form. On the basis of application type, the antithrombin market is categorized into therapeutics, research, and diagnostics & others.


Based on source, the antithrombin market is segmented into human, goat milk (recombinant), and others. Based on dosage form, the market is segmented into lyophilized form and liquid form. Geographically, the market is segmented into four major regions, namely North America, Europe, Asia Pacific, and the Rest of the World. The regions are further categorized into countries.


To get information on various segments, share your queries with us


Along with this, the report provides an elaborative analysis of market dynamics and competitive landscape. Various key insights provided in the report are key brand analysis, key industry developments - mergers, acquisitions and partnerships, reimbursement scenario, and key performance indicators for the global antithrombin market


SEGMENTATION


























ATTRIBUTE



 DETAILS



By Application



·      Therapeutics


·      Research


·      Diagnostics & Others



By Source



·      Human


·      Goat Milk (Recombinant)


·      Others



By Dosage Form


 



·      Lyophilized


·      Liquid



By Geography



·      North America (USA and Canada)


·      Europe (UK, Germany, France, Italy, Spain, and Rest of Europe)


·      Asia Pacific (Japan, China, Australia & New Zealand, and Rest of Asia Pacific)


·      Rest of the World



 


Key Industry Developments



  • In Feb 2009, The Food and Drug Administration (FDA) has approved an Rx called ATryn, which is made from goats genetically altered to produce the blood-thinning protein antithrombin.

  • In Jan 2013, GTC Biotherapeutics, Inc., an LFB Group Company, announced name change to revo biologics and renewed commitment to Evolving Recombinant Medicine.


Frequently Asked Questions

Fortune Business Insights says that the value of the global Antithrombin Market was USD 490.4 Million in 2018.

The Antithrombin Market is projected to reach USD 725.2 Million by 2026.

The Antithrombin Market will grow at the rate of 4.1% CAGR.

Antithrombin Market Size, Share and Global Industry Trend Forecast till 2026
  • PDF
  • 2018
  • 2014-2018
  • 135

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X